From the guest editors: the dramatic advances in the treatment of metastatic renal cancer that have occurred over the last 3 years, with an eye toward the potential future directions of the field.
Wolfram E
WE
Samlowski
Nicholas J
NJ
Vogelzang
D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D015994:Incidence; D007680:Kidney Neoplasms / Q000453:epidemiology / Q000473:pathology / Q000628:therapy*; D009392:Nephrectomy / Q000379:methods
D000970:Antineoplastic Agents